Log in to save to my catalogue

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of...

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67585096

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance

About this item

Full title

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance

Publisher

Japan: Springer Japan

Journal title

Journal of gastroenterology, 2009-08, Vol.44 (8), p.864-870

Language

English

Formats

Publication information

Publisher

Japan: Springer Japan

More information

Scope and Contents

Contents

Purpose
A considerable number of chronic hepatitis B (CH-B) patients remain under continuous lamivudine treatment, although switching treatment to entecavir could be beneficial. We investigated the antiviral efficacy of switching treatment to entecavir in CH-B patients without apparent evidence of lamivudine resistance during the preceding lamiv...

Alternative Titles

Full title

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67585096

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67585096

Other Identifiers

ISSN

0944-1174

E-ISSN

1435-5922

DOI

10.1007/s00535-009-0076-0

How to access this item